Kantar Health Uncovers Opportunities and Challenges for Biosimilars in Asia

Share Article

Kantar Health Presentation at EphMRA Asia Conference to Deliver New Insights

Kantar Health, a leading global healthcare consulting firm, will release new details on biosimilar opportunities and challenges for pharmaceutical manufacturers in Asia at the EphMRA 2013 Asia Conference on November 14 in Singapore. Questa Lin, General Manager, Taiwan, and Simon Li, General Manager, China, will present.

In their presentation, “Uncover Biosimilars Opportunities and Challenges – Utilising Market Insights,” Ms. Lin and Mr. Li will provide a comprehensive understanding of the opportunities and barriers for developing biosimilars, how to apply market access strategies, and the research required to produce forecasting estimates.

In addition, Alice Lee, Regional Talent Director at Kantar Health, will participate in the panel discussion “Talent Management Issues” on November 13, which will focus on challenges in recruiting and retaining market researchers.

Kantar Health is a Silver Sponsor of the EphMRA 2013 Asia Conference. More information on this event can be found at http://www.ephmra.org/events/2013-asia-conference.aspx.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Stacy Sevcik
Kantar Health
+1 (314) 529-3062
Email >
@Kantar_Health
since: 09/2009
Follow >
Follow us on
Visit website